These results suggest that inhibiting the attenuation of skin and lung tissue fibrosis in the BLM-induced SSc mouse model was achieved by decreasing the proportion of IL-4 + CD4 + Th2 cells in the spleen through deleting TLR7. This evidence concerns the gene IL4 and systemic sclerosis.